Literature DB >> 27305625

Blood-Based Screening for Colon Cancer: A Disruptive Innovation or Simply a Disruption?

Ravi B Parikh1, Vinay Prasad2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27305625     DOI: 10.1001/jama.2016.7914

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

Review 1.  Cancer drug development: The missing links.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-08

2.  Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice.

Authors:  Theodore R Levin
Journal:  Am J Gastroenterol       Date:  2016-11-01       Impact factor: 10.864

Review 3.  Updates on Translational Research on Prevention of Polyps and Colorectal Cancer.

Authors:  Elena M Stoffel
Journal:  Clin Colon Rectal Surg       Date:  2018-05-01

Review 4.  Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David Lieberman; Douglas J Robertson
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

Review 5.  Developing DNA methylation-based diagnostic biomarkers.

Authors:  Hyerim Kim; Xudong Wang; Peng Jin
Journal:  J Genet Genomics       Date:  2018-02-17       Impact factor: 5.723

6.  CDKN2A methylation in esophageal cancer: a meta-analysis.

Authors:  Chongchang Zhou; Jinyun Li; Qun Li
Journal:  Oncotarget       Date:  2017-07-25

Review 7.  Colorectal cancer screening: An updated review of the available options.

Authors:  Iyad A Issa; Malak Noureddine
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

Review 8.  Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.

Authors:  Meng Ye; Tao Huang; Ying Ying; Jinyun Li; Ping Yang; Chao Ni; Chongchang Zhou; Si Chen
Journal:  Oncotarget       Date:  2017-02-07

9.  Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients.

Authors:  Xuebing Yan; Liguo Liu; Hao Li; Huanlong Qin; Zhenliang Sun
Journal:  Onco Targets Ther       Date:  2017-10-17       Impact factor: 4.147

10.  Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.

Authors:  Shumin Ni; Meng Ye; Tao Huang
Journal:  Oncotarget       Date:  2017-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.